Report Detail

Pharma & Healthcare Global (United States, European Union and China) Keloid Treatment Market Research Report 2019-2025

  • RnM3675130
  • |
  • 16 August, 2019
  • |
  • Global
  • |
  • 118 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Keloid is an overgrowth of the scar tissues that develop from a wound. Keloid development usually happens after the wound has healed. Keloids grow beyond the border of a scar and develop into a lump. The cause of keloid development cannot be determined but it can develop after surgery, burn injury, piercing, trauma, acne, vaccination and other wounds or cuts. According to the National Institute of Health, keloid scars are commonly seen in people in the age group 10 to 30 years of age.
Excision treatment type segment is anticipated to reach a market value of US$ 1,172.1 Mn by 2025 end, expanding at a CAGR of 3.4% during the forecast period.
In 2019, the market size of Keloid Treatment is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Keloid Treatment.

This report studies the global market size of Keloid Treatment, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Keloid Treatment sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Novartis
Sensus
RXi
Sonoma
Perrigo
Bristol-Myers Squibb
Pacific World
Valeant
Revitol
Avita

Market Segment by Product Type
Occlusive Dressing
Compression Therapy
Cryosurgery
Excision
Radiation Therapy
Laser Therapy
Interferon Therapy
Intralesional Corticosteroid Injection
Others

Market Segment by Application
Hospitals
Dermatology Clinics
Ambulatory Surgical Centres
Others

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Keloid Treatment status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Keloid Treatment manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Keloid Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025


Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Keloid Treatment Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Occlusive Dressing
      • 1.3.3 Compression Therapy
      • 1.3.4 Cryosurgery
      • 1.3.5 Excision
      • 1.3.6 Radiation Therapy
      • 1.3.7 Laser Therapy
      • 1.3.8 Interferon Therapy
      • 1.3.9 Intralesional Corticosteroid Injection
      • 1.3.10 Others
    • 1.4 Market Segment by Application
      • 1.4.1 Global Keloid Treatment Market Share by Application (2019-2025)
      • 1.4.2 Hospitals
      • 1.4.3 Dermatology Clinics
      • 1.4.4 Ambulatory Surgical Centres
      • 1.4.5 Others
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Keloid Treatment Market Size
      • 2.1.1 Global Keloid Treatment Revenue 2014-2025
      • 2.1.2 Global Keloid Treatment Sales 2014-2025
    • 2.2 Keloid Treatment Growth Rate by Regions
      • 2.2.1 Global Keloid Treatment Sales by Regions 2014-2019
      • 2.2.2 Global Keloid Treatment Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Keloid Treatment Sales by Manufacturers
      • 3.1.1 Keloid Treatment Sales by Manufacturers 2014-2019
      • 3.1.2 Keloid Treatment Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Keloid Treatment Revenue by Manufacturers (2014-2019)
      • 3.2.2 Keloid Treatment Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Keloid Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.3 Keloid Treatment Price by Manufacturers
    • 3.4 Key Manufacturers Keloid Treatment Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Keloid Treatment Market
    • 3.6 Key Manufacturers Keloid Treatment Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Occlusive Dressing Sales and Revenue (2014-2019)
      • 4.1.2 Compression Therapy Sales and Revenue (2014-2019)
      • 4.1.3 Cryosurgery Sales and Revenue (2014-2019)
      • 4.1.4 Excision Sales and Revenue (2014-2019)
      • 4.1.5 Radiation Therapy Sales and Revenue (2014-2019)
      • 4.1.6 Laser Therapy Sales and Revenue (2014-2019)
      • 4.1.7 Interferon Therapy Sales and Revenue (2014-2019)
      • 4.1.8 Intralesional Corticosteroid Injection Sales and Revenue (2014-2019)
      • 4.1.9 Others Sales and Revenue (2014-2019)
    • 4.2 Global Keloid Treatment Sales Market Share by Type
    • 4.3 Global Keloid Treatment Revenue Market Share by Type
    • 4.4 Keloid Treatment Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Keloid Treatment Sales by Application

    6 United States

    • 6.1 United States Keloid Treatment Breakdown Data by Company
    • 6.2 United States Keloid Treatment Breakdown Data by Type
    • 6.3 United States Keloid Treatment Breakdown Data by Application

    7 European Union

    • 7.1 European Union Keloid Treatment Breakdown Data by Company
    • 7.2 European Union Keloid Treatment Breakdown Data by Type
    • 7.3 European Union Keloid Treatment Breakdown Data by Application

    8 China

    • 8.1 China Keloid Treatment Breakdown Data by Company
    • 8.2 China Keloid Treatment Breakdown Data by Type
    • 8.3 China Keloid Treatment Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Keloid Treatment Breakdown Data by Company
    • 9.2 Rest of World Keloid Treatment Breakdown Data by Type
    • 9.3 Rest of World Keloid Treatment Breakdown Data by Application
    • 9.4 Rest of World Keloid Treatment Breakdown Data by Countries
      • 9.4.1 Rest of World Keloid Treatment Sales by Countries
      • 9.4.2 Rest of World Keloid Treatment Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Novartis
      • 10.1.1 Novartis Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Keloid Treatment
      • 10.1.4 Keloid Treatment Product Introduction
      • 10.1.5 Novartis Recent Development
    • 10.2 Sensus
      • 10.2.1 Sensus Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Keloid Treatment
      • 10.2.4 Keloid Treatment Product Introduction
      • 10.2.5 Sensus Recent Development
    • 10.3 RXi
      • 10.3.1 RXi Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Keloid Treatment
      • 10.3.4 Keloid Treatment Product Introduction
      • 10.3.5 RXi Recent Development
    • 10.4 Sonoma
      • 10.4.1 Sonoma Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Keloid Treatment
      • 10.4.4 Keloid Treatment Product Introduction
      • 10.4.5 Sonoma Recent Development
    • 10.5 Perrigo
      • 10.5.1 Perrigo Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Keloid Treatment
      • 10.5.4 Keloid Treatment Product Introduction
      • 10.5.5 Perrigo Recent Development
    • 10.6 Bristol-Myers Squibb
      • 10.6.1 Bristol-Myers Squibb Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Keloid Treatment
      • 10.6.4 Keloid Treatment Product Introduction
      • 10.6.5 Bristol-Myers Squibb Recent Development
    • 10.7 Pacific World
      • 10.7.1 Pacific World Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Keloid Treatment
      • 10.7.4 Keloid Treatment Product Introduction
      • 10.7.5 Pacific World Recent Development
    • 10.8 Valeant
      • 10.8.1 Valeant Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Keloid Treatment
      • 10.8.4 Keloid Treatment Product Introduction
      • 10.8.5 Valeant Recent Development
    • 10.9 Revitol
      • 10.9.1 Revitol Company Details
      • 10.9.2 Company Description and Business Overview
      • 10.9.3 Sales, Revenue and Market Share of Keloid Treatment
      • 10.9.4 Keloid Treatment Product Introduction
      • 10.9.5 Revitol Recent Development
    • 10.10 Avita
      • 10.10.1 Avita Company Details
      • 10.10.2 Company Description and Business Overview
      • 10.10.3 Sales, Revenue and Market Share of Keloid Treatment
      • 10.10.4 Keloid Treatment Product Introduction
      • 10.10.5 Avita Recent Development

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Keloid Treatment Sales Channels
      • 11.2.2 Keloid Treatment Distributors
    • 11.3 Keloid Treatment Customers

    12 Market Forecast

    • 12.1 Global Keloid Treatment Sales and Revenue Forecast 2019-2025
    • 12.2 Global Keloid Treatment Sales Forecast by Type
    • 12.3 Global Keloid Treatment Sales Forecast by Application
    • 12.4 Keloid Treatment Forecast by Regions
      • 12.4.1 Global Keloid Treatment Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Keloid Treatment Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      Summary:
      Get latest Market Research Reports on Keloid Treatment. Industry analysis & Market Report on Keloid Treatment is a syndicated market report, published as Global (United States, European Union and China) Keloid Treatment Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Keloid Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,280.00
      $4,920.00
      $6,560.00
      2,463.28
      3,694.92
      4,926.56
      2,938.88
      4,408.32
      5,877.76
      472,320.00
      708,480.00
      944,640.00
      274,011.20
      411,016.80
      548,022.40
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report